title: [The preoperative embolization of the hepatic artery in patients with malignant liver tumors].
abstract: Hepatic artery embolization (HAE) was performed in 4 patients with liver tumors 5-60 days prior to radical resection. No adverse effects of HAE on the liver or gallbladder were observed at surgery. Intraoperative blood loss was reduced in 2 patients. Surgery was completed with intraportal chemotherapy. At 6-26 months post-surgery, all the patients were alive with no evidence of disease. It was concluded that preoperative HAE may be used in treatment of liver malignancies.
authors: A M
authors: AM
authors: Granov
authors: P G
authors: PG
authors: Tarazov
mesh_terms: D000328:Adult; D002406:Catheterization, Peripheral; D003131:Combined Modality Therapy; D004621:Embolization, Therapeutic; D005069:Evaluation Studies as Topic; D005260:Female; D006498:Hepatectomy; D006499:Hepatic Artery; D006801:Humans; D008113:Liver Neoplasms / Q000098:blood supply / Q000401:mortality / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D011169:Portal Vein; D011182:Postoperative Care / Q000379:methods; D011300:Preoperative Care / Q000379:methods*; D005641:Tegafur / Q000008:administration & dosage
chemical_list: D005641:Tegafur
vernacular_title: Predoperatsionnaia émbolizatsiia pechenochnoĭ arterii u bol'nykh so zlokachestvennymi opukholiiami pecheni.